PT  - JOURNAL ARTICLE
AU  - Tan, Li
AU  - Kang, Xia
AU  - Zhang, Bo
AU  - Zheng, Shangen
AU  - Liu, Bo
AU  - Yu, Tiantian
AU  - Yang, Fan
AU  - Wang, Qiongshu
AU  - Miao, Hongming
TI  - A special case of COVID-19 with long duration of viral shedding for 49 days
AID  - 10.1101/2020.03.22.20040071
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.22.20040071
4099  - http://medrxiv.org/content/early/2020/03/27/2020.03.22.20040071.short
4100  - http://medrxiv.org/content/early/2020/03/27/2020.03.22.20040071.full
AB  - Prolonged viral shedding is associated with severe status and poor prognosis of COVID-19 patients. Unexpectedly, here we report a non-severe patient with the longest duration of viral shedding. According to the investigation on the clinical and epidemiological information of this case, we concluded that this type of virus might have a low toxicity and transmissibility, but have a prolonged infective ability and was hardly to be eliminated in the body with regular therapy. However, infusion of plasma from recovered patients showed high efficiency in elimination of this virus. Our findings might shed light on the management of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is a descriptive study, not a trial.Funding StatementThis work was supported in part by award numbers 81872028 and 81672693 (H.M.) from the National Natural Science Foundation of China, cstc2017jcyjBX0071 (H.M.) from the Foundation and Frontier Research Project of Chongqing and T04010019 (H.M.) from the Chongqing Youth Top Talent Project.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the raw data can be provided by the corresponding authors upon reasonable request.